MINNEAPOLIS, March 25, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple™-branded Ella™ Automated Immunoassay platform ...
Bio-Techne TECH is making notable strides in its four growth verticals, which are poised to help it grow in the upcoming quarters. The company is now pursuing clinical diagnostic opportunities on the ...
Bio-Techne (TECH) announced a strategic partnership with ALZpath to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer’s disease. The collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results